(Q44897892)

7 December 2017

title

Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal (English)

1 reference

7 December 2017

1 reference

James A Dowell

1

1 reference

7 December 2017

William Knebel

2

1 reference

7 December 2017

Tom Ludden

3

1 reference

7 December 2017

Marty Stogniew

4

1 reference

7 December 2017

David Krause

5

1 reference

7 December 2017

Tim Henkel

6

1 reference

7 December 2017

publication date

1 June 2004

1 reference

The Journal of Clinical Pharmacology

7 December 2017

published in

1 reference

7 December 2017

volume

44

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

590-598

1 reference

New drugs and novel targets for treatment of invasive fungal infections in patients with cancer

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265644

In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265644

Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265644

In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265644

21 January 2018

Identifiers

DOI

10.1177/0091270004265644

1 reference

7 December 2017

1 reference